Aphex Pharma SolutionsAphex Pharma Solutions
Aphex Pharma Solutions
Home
About Us
Events
PDC 2026
Past PDCs
Contact Us
Aphex Pharma SolutionsAphex Pharma Solutions

Your partner in Pharmaceutical Quality, CMC and regulatory solutions

    ABOUT US

    Home
    About Us
    Event Bookings
    Contact

    SERVICES

    Quality Management
    CMC Advisory
    CMC Regulatory
    Drug Discovery
    Training
    Recruitment

    RESOURCES

    PDC
    Past PDCs
    Become a PDC 2026 Sponsor
    Terms & Conditions
Copyright © 2026 Aphex Pharma SolutionsABN 93 666 546 845Admin
Website designed and maintained by Webifex Labs
Past PDCs

Aphex Pharma Solutions

HomePDC 2026Past PDCs

Past PDCs

Exploring the evolution of pharmaceutical innovation through our historical conferences.

Archive Collection

Past PDC Events

Exploring the evolution of pharmaceutical innovation through our historical conferences.

2025

Chronicle
2025-09-09
Holiday Inn, Warwick Farm

PDC 2025

The 2nd Pharmaceutical Development Conference (PDC) 2025 was another outstanding success. Held in Sydney on September 9, 2025 at Holiday Inn, Warwick Farm, the event continued to build on the success of the inaugural conference.

  • 18+ Scientific Presentations
  • Industry Leaders & Experts
  • Real-World Case Studies
  • Knowledge Sharing Sessions
  • Professional Networking
Keynote Speaker

Dr. Christian Toouli

Chief Executive Officer and Managing Director at FivepHusion

Company Story and Product Development Updates

Dr. Jerome Sarris

Chief Scientific Officer and Co-Founder at Neurala Biosciences

Dr. Adrian Sulistio

Manager Product Development at Amplia Therapeutics

Speakers

Luke Edington

Clinical Projects Manager at DataPharm Australia

Dr Jason Wang

Site Head at Resolian Bioanalytics

Dr. Thomas De Ridder

Veterinarian and Research Scientist, QBiotics

Dr. Helen Ormandy

Executive Director at Precision for Medicine

Dr. Babaji Yadav

Principal Consultant at Scendea

Dr. Daniel Morrison

Clinical Research Associate and Medical Writer at Datapharm Australia

Dr. Gabriel Vigano

Data Programmer and Analyst at Datapharm Australia

Holly Stefl

Chief Commercial Officer at Endpoints Capital

Tara Cassidy

Business Development Lead at Charles River

Dr. Michael Andrews Luke

CEO and Managing Director at Formulytica

Dr. Igor Chekhtman

Senior Scientist (CMC and Workforce Training) at MMIC

Dr. Sarika Namjoshi

Vice President - CMC at Tissue Repair Ltd

Ana Benatti

Expert

Dr. David Neale

Associate Scientist at Ab Initio Pharma Pty Ltd

Dr. Angela Drew

VP, US Regulatory Strategy at Premier Consulting

Dr. Ashish Kumar

Sales and Product Manager at Anton Paar

Ahsan Syed Ali

Director of Quality and CMC regulatory, QBiotics

Supported By Leading Organisations

Aphex Pharma SolutionsAphex Pharma Solutions
Scendea
Resolian
Datapharm Australia
Endpoint
MMIC
Formulytica
Cloud The App
Laftech
Ab Intio
Charles River Laboratories
Anton Paar
Pia Pharma
Opira
Biomerieux
Alithia
Premier Research
Symbio

2024

Chronicle
2024-10-22
Macquarie Park

PDC 2024

The inaugural Pharmaceutical Development Conference (PDC) 2024 was an outstanding success, exceeding all expectations. The event attracted participants from across NSW, VIC, WA, SA, QLD, and New Zealand, with the industry's response being overwhelmingly positive.

  • 15+ Scientific Presentations
  • Industry Leaders & Experts
  • Real-World Case Studies
  • Knowledge Sharing Sessions
  • Professional Networking
Speakers

Dr Paul Reddell

Executive Director and Chief Scientific Officer at QBiotics Group

Kurt Sales

Chief Scientific Officer at Agilex Biolabs Pty Ltd

Lynne Clapham

Principal Toxicologist at Agilex Biolabs Pty Ltd

Luke Edington

Clinical Projects Manager at DataPharm Australia

Dr Matthew Borg

BIOSTATISTICIAN | MBBS, BMEDSCI(HONS), GBIOSTAT, MBIOSTAT, PHD

Helen Ormandy

Senior Director, Clinical Operations, APAC at Precision for Medicine

Gillian Ryan

Global Head of Early Phase at George Clinical

Saurabh Jain

Executive Chairman at Opyl Limited

Richard Buchta

Managing Director and Director Formulytica

Michael Andrews Luke

Expert

Rudy Flach

Senior Vice President R&D at NovaCina

Ashish Kumar

Product & Sales Manager at Anton Paar

Andrew Watson

Director at CBE Pty Ltd (Asia Pacific)

Justine Mann

Chief Executive Officer at CBE Pure Solutions

Ana Benatti

Expert

Ahsan Syed Ali

Director of Quality and CMC regulatory, QBiotics

Dilshani Fernando

Quality Specialist at IQVIA

Supported By Leading Organisations

Aphex Pharma SolutionsAphex Pharma Solutions
Formulytica
NovaCina
Agilex Biolabs
Datapharm Australia
CBR Pure SolutionsCBR Pure Solutions
Cloud The App
Anton Paar
IWT Techniplast Pharma
Laftech
TrialKey
Netzsch